MolecuLight announces integration of its i:X fluorescence imaging device with Net Health’s tissue analytics API programme

271

integrateMolecuLight has partnered with Tissue Analytics, a Net Health company that provides software for the woundcare industry. The purpose of the partnership is to integrate the MolecuLight platform with Net Health’s Tissue Analytics application programming interface (API) programme.

For clinical sites using both MolecuLight and Tissue Analytics, wound care clinicians can now upload standard and fluorescence images captured with the MolecuLight i:X device to the patient’s record in the electronic health record (EHR) platform. The integrated platforms allow clinicians to optimise their workflow and document their patients’ wounds digitally.

“As the use of our MolecuLight i:X platform is growing rapidly across multiple healthcare settings, so too is the need for EHR integration of our images and digital wound measurements,” says Anil Amlani, MolecuLight’s CEO. “We are proud to announce our strategic alliance with Net Health and Tissue Analytics to provide documentation of patients’ wounds, including wound measurement and changes in bacterial burden.”

“The MolecuLight i:X is the only point-of-care device enabling clinicians to capture wound images that depict the presence of clinically significant bacteria, and these are extremely helpful in informing clinical decision making to ensure the fastest path to healing,” Amlani continues. “The integration with Tissue Analytics via the API programme will greatly assist in incorporating this additional information into existing documentation protocols.”

The use of the MolecuLight i:X fluorescence device for imaging of bacterial burden in wounds has transformed assessment and bacterial management practices at Northwell Health Comprehensive Wound Healing Center in Lake Success, New York, according to Alisha Oropallo, director of the Northwell Health Comprehensive Wound Healing Center. “The device provides immediate information on the presence of elevated bacterial burden in wounds, which has dramatically improved our treatment planning and patient care,” she says. “As we use Tissue Analytics for wound documentation, the ability to integrate the MolecuLight imaging platform with our wound documentation system will allow us to further optimise our clinical workflow and offer the MolecuLight platform to wound care facilities across the Northwell network of hospitals.”

“The advances seen in wound care technology over the past five years are remarkable and provide many benefits to patients, payers, and the healthcare industry as a whole,” says Josh Pickus, CEO of Net Health.  “Our company is playing a vital role in connecting innovators like MolecuLight with not only one of the nation’s leading digital imaging platforms for wound care but also its top specialty EHR. This latest agreement highlights our ongoing commitment to working with leading-edge partners who are committed to bringing the innovations that will manage costs, empower clinicians, and, most importantly, improve the lives of those with debilitating wounds.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here